FilingIndex
SC 13DThe Stakes

Keros Therapeutics, Inc. files SC 13D

Filed Apr 23, 2020 · 6y ago · Accession 0001193125-20-117128

Plain English

Activist stake — an investor has acquired more than 5% with intent to influence.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KROS
CIK
1664710
Form type
SC 13D
Filing date
Apr 23, 2020
Report date
Document
d921303dsc13d.htm
Size
133 KB